Vor Biopharma (VOR) Change in Acquisitions & Divestments (2022 - 2026)

Vor Biopharma (VOR) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $13.3 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 1331000.0% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $18.3 million, a 65.45% decrease from a year earlier, with the FY2025 full-year figure at $5.0 million, down 95.33% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $13.3 million, up from $5.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for VOR reached as high as $54.0 million in Q1 2024 and fell as low as -$1000.0 in Q2 2025.
• Historically, Change in Acquisitions & Divestments has averaged $25.6 million across 5 years, with a median of $24.2 million in 2022.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 100.0% in 2025 and soared 1331000.0% in 2026, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $21.4 million in 2022, then increased by 25.99% to $27.0 million in 2023, then soared by 96.3% to $53.0 million in 2024, then slumped by 90.57% to $5.0 million in 2025, then surged by 166.22% to $13.3 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $13.3 million in Q1 2026, $5.0 million in Q4 2025, and -$1000.0 in Q2 2025.